| Name |
Lasokun 750 mg tablete s produljenim oslobađanjem |
| Marketing Authorisation Number |
HR-H-488250069 |
| Active Substance |
ranolazin |
| Composition |
jedna tableta sadrži 750 mg ranolazina |
| Pharmaceutical Form |
Tableta s produljenim oslobađanjem |
| Manufacturer |
Elpen Pharmaceutical Co.Inc. (SA), Pikermi, Attica, Grčka |
| Marketing Authorisation Holder |
Zentiva k.s., U Kabelovny 130, Dolni Mecholupy, Prag 10, Češka |
| Marketing Authorisation Date |
12.12.2024 |
| MA Period of Validity |
12.12.2029 |
| Classification Number |
UP/I-530-09/21-01/175 |
| Registration Number |
381-12-01/70-24-07 |
| Prescription |
Medicinal product subject to medical prescription |
| Type of prescription |
Medicinal product on medical prescription for renewable delivery
|
| Distribution |
Supply through pharmacies (community) |
| Advertising to general public |
not allowed |
| ATC Code |
C01EB18 |
| SmPC |
download |
| PL |
download |
| Public Assessment Report |
download
|
| Summary of risk management plan |
download |
